Verified Nov 2026
Other
·

Seattle, Washington
·
Since 2014
Tasso, Inc. is a Seattle-based medical device company founded in 2014 with 50–100 employees and estimated revenue of $10–50 million. The company develops at-home blood collection devices that enable patients to self-collect clinical-grade samples with minimal discomfort for diagnostic testing and clinical trials. It serves biopharmaceutical companies, healthcare providers, and clinical researchers in automotive, electric-vehicle, medical, and industrial-equipment sectors.
Tasso, Inc. at a glance
Revenue
$10-50M
Est. band
Employees
50-100
Founded
2014
Headquarters
Seattle, Washington
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Tasso, Inc. is a Seattle-based medical device company founded in 2014 with 50–100 employees and estimated revenue of $10–50 million. The company develops at-home blood collection devices that enable patients to self-collect clinical-grade samples with minimal discomfort for diagnostic testing and clinical trials. It serves biopharmaceutical companies, healthcare providers, and clinical researchers in automotive, electric-vehicle, medical, and industrial-equipment sectors.
At a glance
Attribute | Detail |
|---|---|
Founded | 2014 |
Headquarters | Seattle, Washington |
Employees | 50-100 |
Revenue | $10-50M (estimated) |
What Tasso, Inc. makes
Tasso manufactures disposable blood collection devices including the T+, Tasso20, and TassoST models, which use a push-button mechanism and are under review for FDA Class II medical device approval.
Products and capabilities described on the company's own site include LED (source: tassoinc.com).
Latest developments
2026-03-31 — Partnership between Tasso and the Parkinson’s Foundation Reveals New Genetic Data — Tasso, Inc. (tassoinc.com)
2026-03-05 — 【グループニュース】H.U.POCkeT:新日本科学Tassoと販売店契約を締結 | H.U.グループホールディングス株式会社のプレスリリース (prtimes.jp)
2026-03-05 — A press release has been issued from SNBL Tasso Co., Ltd. | News | SNBL (snbl.com)
2026-02-04 — InnoVero and Tasso, Inc. Selected to Deploy Secure, Virtually Painless Anti-Doping Technology at the 2026 Olympic Winter Games — Tasso, Inc. (tassoinc.com)
2025-11-20 — Neurogen Biomarking Enters Partnership Agreement with Tasso to Bring Virtually Painless Blood Collection Technology to Its Alzheimer’s Testing Platform — Tasso, Inc. (tassoinc.com)
2025-07-15 — Tasso Secures Additional North American and European Regulatory Clearances for Tasso™ Mini Device — Tasso, Inc. (tassoinc.com)
Company details
The company has established partnerships with organizations including the Parkinson's Foundation and Neurogen Biomarking to integrate its virtually painless collection technology into diagnostic and research platforms. Tasso, Inc. was founded in 2014, has an estimated 50-100 employees, and is headquartered in Seattle, Washington.
Frequently asked questions
What does Tasso, Inc. do?
Tasso, Inc. is a Seattle-based medical device company founded in 2014 with 50–100 employees and estimated revenue of $10–50 million. The company develops at-home blood collection devices that enable patients to self-collect clinical-grade samples with minimal discomfort for diagnostic testing and clinical trials. It serves biopharmaceutical companies, healthcare providers, and clinical researchers in automotive, electric-vehicle, medical, and industrial-equipment sectors.
Where is Tasso, Inc. headquartered?
Tasso, Inc. is headquartered in Seattle, Washington (1631 15th Avenue West, Seattle, Washington, 98119).
When was Tasso, Inc. founded?
Tasso, Inc. was founded in 2014.
How big is Tasso, Inc.?
Tasso, Inc. has an estimated 50-100 employees, with revenue in the $10-50M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
